<DOC>
	<DOCNO>NCT00369499</DOCNO>
	<brief_summary>The primary objective Study compare effect transcatheter device closure atrial shunt non-closure control group period cessation procedure relate medication 3 month 9 month post randomization determine proportion patient experience 50 % reduction baseline monthly migraine attack frequency group .</brief_summary>
	<brief_title>STOP PAIN : Septal Closure PFO - Does Prevent Migraine ?</brief_title>
	<detailed_description />
	<mesh_term>Migraine Disorders</mesh_term>
	<criteria>Migraine history least 1 year . Migraine patient experience least 2 migraine attack per month . Migraine patient experience least 1 migraine attack aura per month . Failure intolerance least 2 class prophylactic migraine medication evaluate adequate , approved medication trial . At least one class shall come betablockers , anticonvulsant , calcium channel blocker tricyclic antidepressant . Aged 18 50 year legal age host country . The patient legal guardian sign study specific inform consent form agree data collection followup requirement . The patient agree abstain start prophylactic migraine medication agree maintain exist prophylactic migraine medication without change dose drug enter baseline period throughout duration study final assessment . Documented right left shunt suitable device closure . Taking migraine preventative medication condition migraine . History 15 headache day per month . 8 nonmigraine headache day per month . Overuse acute headache medication ( use 10 day per month ) . Patient severe central nervous system disease seizure disorder , inflammatory disease central nervous system , previous stroke . Previous surgical device closure PFO ASD . Artificial heart valve . Pacemaker ICD implant within past 3 month . Anatomic variant could affect successful deployment coronary sinus , pulmonary vein , Chiari network . Uncontrolled bacteremias dental surgical procedure within past 30 day plan within study period . Allergy contrast medium , and/or component device use . Contraindicated medication use procedure . History atrial fibrillation atrial flutter ( chronic paroxysmal ) . Patient enrol intend participate another clinical study ( investigational drug device , new indication approve drug device , requirement additional test beyond standard clinical practice ) study within four week prior his/her enrollment study . Patient undergoing dialysis renal failure . Patient NYHA class 3 4 cardiac failure . Patient pregnant , intend become pregnant trial period . Patient require anticoagulation therapy concomitant condition .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>February 2008</verification_date>
</DOC>